Clinical Trials in North Carolina

Showing 1821-1840 of 9,731 trials

Clinical Evaluation of WaveLight Plus LASIK

NCT07127757

This study is a single-site, single-arm, prospective, observational study of subject satisfaction, quality of vision, and quality of life after bilateral LASIK surgery. Subjects will be assessed up to 3 months post-operatively. Clinical evaluations will include refractive outcomes, visual acuity, and administration of the adapted PROWL and Low Luminance Questionnaire (LLQ-32) Questionnaire.

MyopiaAstigmatism

Laser Defined Vision50 participantsStarted Aug 2025

Greensboro, North Carolina, United States

COMPLETEDPhase 1/241 miles

Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia

NCT05184764

Phase 1b/2a, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Escalation Study of the Safety, Tolerability, and Efficacy of Intravenous AP SA02 as an Adjunct to Best Available Antibiotic Therapy Compared to Best Available Antibiotic Therapy Alone for the Treatment of Adults With Bacteremia Due to Staphylococcus aureus

BacteremiaStaphylococcus AureusStaphylococcus Aureus Bacteremia+2 more

Armata Pharmaceuticals, Inc.50 participantsStarted Apr 2022

Tucson, Arizona, United States • La Jolla, California, United States • Los Angeles, California, United States +25 more locations

Clinical Evaluation of WaveLight Plus LASIK

Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia

Find Trials by Condition in North Carolina

A Clinical Study to Evaluate DNTH103 in Adults With Multifocal Motor Neuropathy

Expanded Access Protocol for Patients With Eosinophilic Esophagitis

MB-105 in Patients With CD5 Positive T-cell Lymphoma

A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies

P-15L Bone Graft in Transforaminal Lumbar Interbody Fusion With Instrumentation

Hyperbaric Oxygen Brain Injury Treatment Trial

Double-blind, Randomized, Placebo-controlled, Prospective Phase III Study Evaluating Efficacy and Safety of Panzyga in Primary Infection Prophylaxis in Patients With Chronic Lymphocytic Leukemia ("PRO-SID" Study)

A Study Investigating the Efficacy and Safety of LBL-007 Plus Tislelizumab in Combination With Bevacizumab Plus Fluoropyrimidine Versus Bevacizumab Plus Fluoropyrimidine in Participants With Unresectable or Metastatic Colorectal Cancer

Efficacy and Safety of Four Doses of Cenerimod Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus

Study of Selinexor in Combination With Backbone Treatments or Novel Therapies In Participants With Relapsed or Refractory (RR) Diffuse Large B-Cell Lymphoma (DLBCL)

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Lacosamide in Neonates With Repeated Electroencephalographic Neonatal Seizures

Testing the Addition of an Anti-cancer Immune Therapy Drug (Nivolumab) to the Usual Chemotherapy Treatment (Cisplatin or Carboplatin With Gemcitabine) for Recurrent or Metastatic Nasopharyngeal Cancer

Biobank For MS And Other Demyelinating Diseases

A Study of Ponatinib With Chemotherapy in Children, Teenagers, and Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Improving Outcomes Assessment in Chronic GVHD

Comparing Surgery Versus Standard Physical Therapy in Treating People With a Meniscal Tear and Osteoarthritis

Identification of Predictors for Clinical Outcomes in Femoroacetabular Impingement Surgery

Tazemetostat+Nivo/Ipi in INI1-Neg/SMARCA4-Def Tumors